Showing 1 - 6 results of 6 for search 'Sylwia Popek-Marciniec', query time: 0.03s
Refine Results
-
1
-
2
<i>WT1</i> Gene Mutations, rs16754 Variant, and <i>WT1</i> Overexpression as Prognostic Factors in Acute Myeloid Leukemia Patients by Dorota Koczkodaj, Szymon Zmorzyński, Beata Grygalewicz, Barbara Pieńkowska-Grela, Wojciech Styk, Sylwia Popek-Marciniec, Agata Anna Filip
Published 2022-03-01
Article -
3
The Relationship of <i>ABCB1/MDR1</i> and <i>CYP1A1</i> Variants with the Risk of Disease Development and Shortening of Overall Survival in Patients with Multiple Myeloma by Szymon Zmorzynski, Magdalena Wojcierowska-Litwin, Sylwia Popek-Marciniec, Aneta Szudy-Szczyrek, Wojciech Styk, Sylwia Chocholska, Agata Anna Filip
Published 2021-11-01
Article -
4
In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Ac... by Szymon Zmorzynski, Sylwia Popek-Marciniec, Beata Biernacka, Aneta Szudy-Szczyrek, Sylwia Chocholska, Wojciech Styk, Joanna Czerwik-Marcinkowska, Grazyna Swiderska-Kolacz
Published 2024-03-01
Article -
5
The Relationship of <i>CCL5</i> and <i>CCR1</i> Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma by Sylwia Popek-Marciniec, Wojciech Styk, Magdalena Wojcierowska-Litwin, Aneta Szudy-Szczyrek, Paul Dudek, Grazyna Swiderska-Kolacz, Joanna Czerwik-Marcinkowska, Szymon Zmorzynski
Published 2023-03-01
Article -
6
Association of Chromosome 17 Aneuploidy, <i>TP53</i> Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment by Sylwia Popek-Marciniec, Wojciech Styk, Magdalena Wojcierowska-Litwin, Sylwia Chocholska, Aneta Szudy-Szczyrek, Marzena Samardakiewicz, Grazyna Swiderska-Kolacz, Joanna Czerwik-Marcinkowska, Szymon Zmorzynski
Published 2023-09-01
Article